Article info
Original articles
Her2 amplification distinguishes a subset of non-muscle-invasive bladder cancers with a high risk of progression
- Correspondence to Dr Chin-Chen Pan, Department of Pathology, Taipei Veterans General Hospital, No. 201, Shi-Pai Rd, Sec.2, Taipei 11217, Taiwan; ccpan{at}vghtpe.gov.tw
Citation
Her2 amplification distinguishes a subset of non-muscle-invasive bladder cancers with a high risk of progression
Publication history
- Received May 11, 2012
- Revised September 19, 2012
- Accepted September 23, 2012
- First published October 19, 2012.
Online issue publication
January 28, 2013
Article Versions
- Previous version (19 October 2012).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions